Delivery Order SPE2DB22D1002-SPE2DB25FKWV9

Award Date 1/17/25
Potential Completion Date 1/21/25
Potential Value $3.9K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $6,646.35 firm-fixed-price delivery order is for the supply of 4,566,296,179 units of the generic medication Ondansetron ODT 4 mg tablets. The contract has a completion date of November 1, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which...
This federal contract award was made by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $20,948.27, is a delivery order that provides for the procurement of 4,566,778,675 units of the prescription drug Ondansetron ODT 4 mg tablets. The contract has a firm fixed price pricing type and a completion date of December 23, 2024. This award is a part of a larger...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $5,078.01 firm-fixed-price delivery order is for the supply of 4,566,338,488 units of the medication Ondansetron ODT 4 mg tablets. The contract has an ultimate completion date of November 6, 2024. This award is a delivery order under AmerisourceBergen's $999,999,999 Indefinite Delivery Contract (IDC) with the DLA...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $25,595.07 firm fixed-price delivery order is for the supply of 4,566,629,069 units of Ondansetron ODT 4 mg tablets. The contract has an ultimate completion date of December 6, 2024. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,812.57 firm fixed-price delivery order is for 4,566,491,946 units of the medication Ondansetron ODT 4 mg Tablet in 30-count packages. The contract has a period of performance through November 20, 2024 and was awarded on November 19, 2024. This delivery order is part of a larger...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp's Corporate Office Division, a subsidiary of the pharmaceutical distribution company Amerisourcebergen Corporation. The contract, valued at $11,144.26, is for the delivery of 4,564,416,404 units of the prescription drug Ondansetron ODT 4 mg tablets. The contract is a delivery order under a larger Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with...
This federal contract award, valued at $4,555.91, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Firm Fixed Price Delivery Order for the supply of 4,566,148,838 units of Ondansetron HCL 4 mg Tablets in 30-count packages. The award has an ultimate completion date of October 21, 2024. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a large pharmaceutical distributor, for the delivery of 4,566,740,595 units of the medication Ondansetron ODT 4 mg tablet. The award, valued at $1,316.14, is a firm fixed-price delivery order with a completion date of December 18, 2024. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) valued at $999,999,999 with the DLA Troop Support Medical, which serves as a...
This federal contract award, valued at $6,699.43, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, the prime contractor, for the delivery of 4,564,128,973 units of Ondansetron ODT 8 mg Tablets. The contract is a firm fixed price delivery order with an ultimate completion date of April 2, 2024. AmerisourceBergen Drug Corp, a subsidiary of the global pharmaceutical distributor AmerisourceBergen Corporation, is the prime contractor on an indefinite delivery...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $5,729.60 firm-fixed-price delivery order is for the supply of 4,565,597,493 units of the drug Ondansetron ODT 4 mg Tablet. The contract has an ultimate completion date of August 28, 2024. This award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop...
  • SPE2DB22D1002
    Indefinite Delivery Contract
  • SPE2DB22D1002-SPE2DB25FKWV9
    Delivery Order

This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $3,896.71, is a delivery order for 4,566,968,587 units of the medication Ondansetron ODT 4 mg tablet. The contract has an ultimate completion date of January 21, 2025 and is a firm fixed-price contract type. AmerisourceBergen Drug Corp is the prime contractor, with no subcontractors mentioned. This award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) the company holds with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract does not have a set-aside designation, indicating open competition.

Generated 4/18/25, 2:09 PM